HIF1A and neoplasm: Future research should focus on elucidating the precise molecular mechanisms governing WWOX-HIF1α interactions, exploring their clinical utility as biomarkers, and developing targeted therapies that exploit this axis to overcome tumour aggressiveness and resistance.